Email bio-eu@licor.com
Dyes for Your Near-Infrared Imaging Needs
Why Target EGFR?
IRDye 680RD EGF Optical Probe is a BrightSite™ near-infrared (NIR) labeled recombinant human epidermal growth factor (EGF). Epidermal growth factor receptor (EGFR) is one of a family of receptor tyrosine kinases found on the surface of epithelial cells, to which EGF binds. Many types of cancer cells have abnormally high EGFR levels on the cell surface (Table 1). In vivo assays of EGF binding have proven effective in monitoring specific solid tumor models that exhibit overexpression of EGFR. EGF conjugated to LI-COR's IRDye 680RD NIR fluorophore provides a versatile probe that can be used for in vitro and in vivo assays, as well as whole organ and tissue section analysis.
Figure 1. Intravenous administration of IRDye 680RD EGF (2 nmol) binds to the A431 tumor located on the right hip Image captured 24 h post injection on the Pearl® Impulse Imaging System.
For research purposes only. Not for diagnostic or therapeutic use. Not for use in humans. LI-COR IRDye reagents are covered by U.S. patents, foreign equivalents, and patents pending.
Shipping information:IRDye is a registered trademark of LI-COR Inc.
Advantages of BrightSite™ Optical Agents
Molar extinction coefficient characteristics of water, hemoglobin and oxygenated hemoglobin (400-1000 nm). IRDye® infrared dyes have ideal excitation/emission wavelengths for in vivo imaging.
IRDye® 680RD EGF Optical Probe is composed of recombinant a EGF polypeptide containing 54 amino acid residues (molecular weight=6.2 kDa) conjugated to the LI-COR IRDye 680RD NIR fluorophore. IRDye® 680RD EGF has been optimized for research pertaining to tumor biology
Properties (in 1X PBS)
Systematic Evaluation of Targeted IRDye® Labeled Optical Imaging Agents
- Joy Kovar, Sr. Scientist
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer
- Dr. Eva Sevick-Muraca and Dr. Shi Ke, Baylor College of Medicine
Cancer Research Webinar Series Part 3: In Vivo Imaging with Near-Infrared Fluorescent Optical Probes
- Dr. Amy Geschwender
Cancer Research Webinar Series Part 5: Target Fluorescent Contrast Agents for Image-Guided Cancer Surgery
- Dr. D. Michael Olive
For related IRDye optical probe-related publications, go to IRDye 800CW EGF Publications.